New issues are emerging nearly a month after the Supreme Court overturned Roe v. Wade—when initial corporate responses tended to focus on health and travel benefits for employees.
What we’re watching:
Stakeholder focus on corporate political giving: Increased scrutiny of corporate PAC activity, especially in cases where there is a perceived disconnect or conflict between the employee policies they shared post-Dobbs and their past giving activity.
Health sector-specific issues: News and social media are covering emerging issues related to healthcare beyond abortion restrictions. A notable example is non-pregnant patients with chronic illnesses or other conditions struggling to access necessary prescribed medications—such as methotrexate for arthritis patients—due to their potential abortifacient side effects.
Data privacy issues: Consumer privacy concerns focus on the use of search engines and apps to search abortion-related topics. That includes tracking health conditions and fertility or purchase products related to reproductive care, personal health and fertility, especially in states that restrict abortions. Tech, health and retail companies may face questions from legislators and regulators about how they are protecting this data.
Litigation & legislative/regulatory retaliation: Companies that publicly announced supportive abortion stances or outlined expanded health and travel benefits may begin to experience backlash from anti-abortion parties and states. This could include the threat of litigation from anti-abortion parties related to corporate travel policies as well as new retaliatory regulation or legislation in anti-abortion states toward companies with supportive travel policies.